HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,225 | +115.2% | 24,837 | +104.5% | 0.10% | +133.3% |
| Q2 2023 | $1,034 | -67.0% | 12,147 | -67.9% | 0.04% | -69.6% |
| Q1 2023 | $3,134 | -99.6% | 37,879 | +228.7% | 0.15% | +184.6% |
| Q3 2022 | $853,000 | -3.7% | 11,524 | -15.2% | 0.05% | -22.4% |
| Q2 2022 | $886,000 | -3.4% | 13,587 | -6.3% | 0.07% | +11.7% |
| Q1 2022 | $917,000 | +25.1% | 14,497 | +4.8% | 0.06% | -34.8% |
| Q4 2021 | $733,000 | -14.4% | 13,829 | +14.0% | 0.09% | -19.3% |
| Q3 2021 | $856,000 | – | 12,129 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |